Iron in heart failure: friend or foe?
Jelani
Qurat-ul-ain
QU
Department of Medicine, Leon H. Charney Division of Cardiology, New York University Langone Medical Center, New York, NY 10016, USA.
Katz
Stuart D
SD
D018798:Anemia, Iron-Deficiency / Q000209:etiology*; D015415:Biomarkers; D004311:Double-Blind Method; D005260:Female; D005290:Ferric Compounds / Q000008:administration & dosage*; D006333:Heart Failure / Q000097:blood* / Q000150:complications; D006454:Hemoglobins / Q000032:analysis*; D006801:Humans; D007501:Iron / Q000097:blood*; D008297:Male; D008320:Maltose / Q000008:administration & dosage / Q000031:analogs & derivatives*; D016896:Treatment Outcome
D015415:Biomarkers; D005290:Ferric Compounds; D006454:Hemoglobins; C522335:ferric carboxymaltose; D008320:Maltose; D007501:Iron